After coupling SPION with anti-HER2 antibody trastuzumab, it was found that anti-HER2SPIONS selectively targeted HER2-expressing cancer cells and induced apoptosis only in cancer cells expressing HER2, suggesting the specificity of this coupling against cancer (53). This evidence concerns the gene ERBB2 and cancer.